Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ronacaleret in distal radius fracture
NCT00548496Phase 2Terminated
- Sponsor
- GSK
- Start
- Sep 2007
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 13
01
Overview
Phase 2, randomised, double-blind trial of ronacaleret in distal radius fracture, sponsored by GSK. Primary endpoint: Fracture healing time at 16 weeks. Started Sep 2007; status: terminated.
02
Drugs
ronacaleret
03
Conditions
distal radius fracture
Beyond the preview
Go deeper on NCT00548496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00548496.